# Phase 1 Study of DS-8895a in Subjects With Advanced Solid Tumors

> **NCT02004717** · PHASE1 · COMPLETED · sponsor: **Daiichi Sankyo Co., Ltd.** · enrollment: 37 (actual)

## Conditions studied

- Solid Tumors

## Interventions

- **DRUG:** DS-8895a

## Key facts

- **NCT ID:** NCT02004717
- **Lead sponsor:** Daiichi Sankyo Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-10
- **Primary completion:** 2017-02
- **Final completion:** 2017-02
- **Target enrollment:** 37 (ACTUAL)
- **Last updated:** 2019-07-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02004717

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02004717, "Phase 1 Study of DS-8895a in Subjects With Advanced Solid Tumors". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02004717. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*